Table: Kringle Pharma - 9-MTH parent results

Kringle Pharma

10/08/2026 07:40

    Aug 10 (Reuters)- 
             Kringle Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to   
                Jun 30, 2026        Jun 30, 2025       Sep 30, 2026  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            323 mln             53 mln            332 mln     
                (+501.0 pct)         (-12.4 pct)       (+360.4 pct)  
  Operating     loss 633 mln        loss 738 mln        loss 1.02    
  Recurring     loss 628 mln        loss 738 mln        loss 1.02    
  Net           loss 631 mln        loss 739 mln        loss 1.02    
  EPS          loss 84.44 yen      loss 108.35 yen   loss 132.34 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T